Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial
Dr. Michael A. Portman and colleagues have published the results of a clinical trial showing benefits by etanercept (brand name Enbrel) for Kawasaki Disease patients. The results were published in the American Academy of Pediatrics journal Pediatrics. The manuscript abstract and publicly available video abstract describing the study can be found via the link below.
For questions and participation in Kawasaki Disease research please email KawasakiDisease@seattlechildrens.org